At the news
? NEUTRALIMPACT 3/10 S-3 filed May 12, 2026 at 17:05 ET
Profound Medical filed an S-3 registration statement to register 921,428 common shares for resale by selling shareholders who acquired them in a December 2025 private placement at $7.00/share. The company is not selling any shares or receiving proceeds from this filing. This is a routine resale registration for existing shareholders, not a new capital raise, and follows strong Q1 2026 results with 104% revenue growth and improved operating performance.
- S-3 registers 921,428 common shares for resale by selling shareholders from a December 2025 private placement
- Shares were issued at $7.00 per share for aggregate gross proceeds of approximately $6.45 million
- Company will not receive any proceeds from the resale of shares under this prospectus
- Filing follows Q1 2026 earnings (May 7) showing 104% revenue growth to $5.3M and net loss improvement of 34% to $0.19/share
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access